<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) development involves underlying modifications at genetic/epigenetic level </plain></SENT>
<SENT sid="1" pm="."><plain>This study evaluated the role of Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation together/independently in <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in Indian population and correlation with clinicopathological variables of the disease </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: One hundred and twenty four consecutive surgically resected tissues (62 tumor and equal number of <z:mpath ids='MPATH_458'>normal</z:mpath> adjacent controls) of primary <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> were included and patient details including demographic characteristics, lifestyle/food or drinking habits, clinical and histopathological profiles were recorded </plain></SENT>
<SENT sid="3" pm="."><plain>Polymerase chain reaction - Restriction fragment length polymorphism and direct sequencing for Kras gene mutation and Methylation Specific-PCR for RASSF1A, FHIT and MGMT genes was performed </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Kras gene mutation at codon 12 &amp; 13 and methylated RASSF1A, FHIT and MGMT gene was observed in 47%, 19%, 47%, 37% and 47% cases, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Alcohol intake and smoking were significantly associated with presence of Kras mutation (codon 12) and MGMT methylation (p-value &lt;0.049) </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> stage and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> correlated with presence of mutant Kras codon 12 (p-values 0.018, 0.044) and methylated RASSF1A (p-values 0.034, 0.044), FHIT (p-values 0.001, 0.047) and MGMT (p-values 0.018, 0.044) genes </plain></SENT>
<SENT sid="7" pm="."><plain>Combinatorial effect of gene mutation/methylation was also observed (p-value &lt;0.025) </plain></SENT>
<SENT sid="8" pm="."><plain>Overall, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage 3, moderately differentiated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, presence of lymphatic invasion and absence of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> was more frequently observed in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with mutated Kras and/or methylated RASSF1A, FHIT and MGMT genes </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Synergistic interrelationship between these genes in <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> may be used as diagnostic/prognostic markers in assessing the overall pathological status of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>